|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||
| Current assets: | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Restricted cash | ||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $3,845 and $7,454 as of September 30, 2025 and December 31, 2024, respectively | ||||||||||||||||||
| Unbilled receivables | ||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||
| Due from related party | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||
| Internal use software, net | ||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||
| Other long-term assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||
| Current liabilities: | ||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||
| Operating lease liabilities, current | ||||||||||||||||||
| Due to related party | ||||||||||||||||||
| Deferred revenue | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Accrued rent | ||||||||||||||||||
| Deferred tax liability, net | ||||||||||||||||||
| Long-term debt, net | ||||||||||||||||||
| Operating lease liabilities, non-current | ||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Common stock, shares authorized (in shares) | ||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||
| Preferred Stock, $0.001 par value, 50,000,000 shares authorized at September 30, 2025; 0 shares issued and outstanding at September 30, 2025 and December 31, 2024 | ||||||||||||||||||
| Common Stock, $0.001 par value, 500,000,000 shares authorized, 166,863,690 and 162,871,266 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | ||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||
| Retained earnings | ||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||
| Preferred stock, shares authorized (in shares) | ||||||||||||||||||
Loading...
